Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas

References

• Bach, P., Milloy, M. J., Nguyen, P., Koehn, J., Guillemi, S., Kerr, T., & Wood, E. (2015). Gender differences in access to methadone maintenance therapy in a Canadian setting. Drug and Alcohol Review, 34, 503–507.
   Google Scholar
• Back, S. E., Payne, R. L., Wahlquist, A. H., Carter, R. E., Stroud, Z., Haynes, L., … Ling, W. (2011). Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. The American Journal of Drug and Alcohol Abuse, 37, 313–323.
   Google Scholar
• Ball, J. C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. New York, NY: Springer-Verlag,
   Google Scholar
• Bawor, M., Dennis, B. B., Varenbut, M., Daiter, J., Marsh, D. C., Plater, C., … Samaan, Z. (2015). Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: A multicenter cohort study. Biology of Sex Differences, 6, 21.
   Google Scholar
• Byrd, R. S., Weitzman, M., & Doniger, A. S. (1996). Increased drug use among old-for-grade adolescents. Archives of Pediatrics and Adolescent Medicine, 150, 470–476.
   Google Scholar
• Deck, D., & Carlson, M. J. (2005). Retention in publicly funded methadone maintenance treatment in two Western States. The Journal of Behavioral Health Services & Research, 32, 43–60.
   Google Scholar
• Eiroá-Orosa, F. J., Verthein, U., Kuhn, S., Lindemann, C., Karow, A., Haasen, C., & Reimer, J. (2010). Implication of gender differences in heroin-assisted treatment: Results from the German randomized controlled trial. The American Journal on Addictions, 19, 312–318.
   Google Scholar
• Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., … Delphin-Rittmon, M. E. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65, 146–157.
   Google Scholar
• Graziani, M., & Nisticò, R. (2015). Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy. Frontiers in Pharmacology, 6, 122.
   Google Scholar
• Grella, C. E., & Lovinger, K. (2012). Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addictive Behaviors, 37, 306–312.
   Google Scholar
• Guarino, H., Marsch, L. A., Deren, S., Straussner, S. L., & Teper, A. (2015). Opioid use trajectories, injection drug use, and hepatitis C virus risk among young adult immigrants from the former Soviet Union living in New York city. Journal of Addictive Diseases, 34, 162–177.
   Google Scholar
• Hawks, R. L. (1986). Analytical methodology. NIDA - Research Monographs, 73, 30–42.
   Google Scholar
• Hernandez-Avila, C. A., Rounsaville, B. J., & Kranzler, H. R. (2004). Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74, 265–272.
   Google Scholar
• Hosmer, D. W., & Lemeshow, S. A. (1980). Goodness-of-Fit test for the multiple logistic regression model. Communications in Statistics, A10, 1043–1069.
   Google Scholar
• Hser, Y. I., Anglin, M. D., & Liu, Y. (1990). A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment. International Journal of Addiction, 25, 1295–1315.
   Google Scholar
• Jimenez-Treviño, L., Saiz, P. A., García-Portilla, M. P., Díaz-Mesa, E. M., Sánchez-Lasheras, F., Burón, P., … Bobes, J. (2011). A 25-source follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences. Addictive Behaviors, 36, 1184–1190.
   Google Scholar
• Kelly, S. M., O'Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence, 117, 170–175.
   Google Scholar
• Kennedy, A. P., Epstein, D. H., Phillips, K. A., & Preston, K. L. (2013). Sex differences in cocaine/heroin users: Drug-use triggers and craving in daily life. Drug and Alcohol Dependence, 132, 29–37.
   Google Scholar
• Levine, A. R., Lundahl, L. H., Ledgerwood, D. M., Lisieski, M., Rhodes, G. L., & Greenwald, M. K. (2015). Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. Journal of Substance Abuse Treatment, 54, 37–43
   Google Scholar
• Lynch, W., Roth, M., & Carroll, M. (2002). Biological basis of sex differences in drug abuse: Preclinical and clinical studies. Psychopharmacology, 164, 121–137
   Google Scholar
• Magura, S., Nwakeze, P. C., & Demsky, S. Y. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51–60.
   Google Scholar
• Mayet, A., Legleye, S., Beck, F., Falissard, B., & Chau, N. (2016). The Gateway Hypothesis, common liability to addictions or the route of administration model a modelling process linking the three theories. European Addiction Research, 22, 107–117.
   Google Scholar
• McCaul, M. E., Svikis, D. S., & Moore, R. D. (2001). Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence, 62, 9–17.
   Google Scholar
• McLellan, A. T., Luborsky, L., O'Brien, C. P., Barr, H. L., & Evans, F. (1984). The Addiction Severity Index in three different populations. NIDA - Research Monographs, 55, 217–223.
   Google Scholar
• Mitchell, M. M., Severtson, S. G., & Latimer, W. W. (2008). Pregnancy and race/ethnicity as predictors of motivation for drug treatment. The American Journal of Drug and Alcohol Abuse, 34, 397–404.
   Google Scholar
• National Institutes of Health. (1997). Effective medical treatment of opiate addiction. NIH Consensus Statement, 15(6), 1–38.
   Google Scholar
• Novick, D. M., Salsitz, E. A., Joseph, H., & Kreek, M. J. (2015). Methadone medical maintenance: An early 21st-century perspective. Journal of Addictive Diseases, 34, 226–237.
   Google Scholar
• Peles, E., & Adelson, M. (2006). Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. Journal of Addictive Diseases, 25, 39–45.
   Google Scholar
• Peles, E., Linzy, S., Kreek, M., & Adelson, M. (2008). One-source and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel. Journal of Addictive Diseases, 27, 11–25.
   Google Scholar
• Peles, E., Schreiber, S., & Adelson, M. (2006). Factors predicting retention in treatment: 10-source experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence, 82, 211–217.
   Google Scholar
• Peles, E., Schreiber, S., & Adelson, M. (2010). 15-Source survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug and Alcohol Dependence, 107, 141–148.
   Google Scholar
• Peles, E., Schreiber, S., & Adelson, M. (2014a). Characteristics and outcome of minority group patients in methadone maintenance treatment. Journal of Psychoactive Drugs, 46, 317–324.
   Google Scholar
• Peles, E., Schreiber, S., & Adelson, M. (2014b). Deleterious effects of benzodiazepine abuse among methadone maintenance treatment patients. Heroin Addiction and Related Clinical Problems, 16, 63–70.
   Google Scholar
• Proctor, S. L., Copeland, A. L., Kopak, A. M., Hoffmann, N. G., Herschman, P. L., & Polukhina, N. (2015). Predictors of patient retention in methadone maintenance treatment. Psychology of Addictive Behaviors, 29, 906–917.
   Google Scholar
• Schiff, M., Levit, S., & Moreno, R. C. (2007). Retention and illicit drug use among methadone patients in Israel: A gender comparison. Addictive Behaviors, 32, 2108–2119.
   Google Scholar
• Schottenfeld, R. S., Pakes, J. R., & Kosten, T. R. (1998). Prognostic factors in buprenorphine-versus methadone-maintained patients. The Journal of Nervous and Mental Disease, 186, 35–43.
   Google Scholar
• Secades-Villa, R., Garcia-Rodríguez, O., Jin, C. J., Wang, S., & Blanco, C. (2015). Probability and predictors of the cannabis gateway effect: A national study. International Journal of Drug Policy, 26, 135–142.
   Google Scholar
• Volkow, N. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. The New England Journal of Medicine, 371, 879.
   Google Scholar